Journal
BRAIN SCIENCES
Volume 11, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/brainsci11050644
Keywords
metabolic syndrome; spatial memory; synaptic plasticity; synaptophysin; GAP-43; allopregnanolone
Categories
Ask authors/readers for more resources
This study evaluated the therapeutic effect of the neurosteroid Allopregnalonone on spatial memory and synaptic plasticity markers in the hippocampus of MetS patients, demonstrating improvement in working spatial memory, hypertension, and biochemical markers in the serum and hippocampus.
Metabolic Syndrome (MetS) is considered a common disorder, especially with a sedentary lifestyle and unhealthy food consumption. Cognitive impairment is one of the MetS consequences that worsens the quality of life of the patients. The study aimed to assess the therapeutic effect of the neurosteroid Allopregnalonone on spatial memory and, therefore, the expression of two synaptic plasticity markers in the hippocampus. Thirty-two male rats were divided into four groups: control groups, MetS, and MetS + Allopregnalone. Spatial memory has been evaluated by the Y-maze task and blood pressure measured by the rat tail method. Biochemical evaluation of serum glucose, insulin, lipid profile, and hippocampal expression of Synaptophysin and Associated Protein 43 (GAP-43) were performed for assessing Allopregnanolone on serum and hippocampal markers. Allopregnanolone therapy improved working spatial memory, hypertension, and biochemical markers measured in the serum and hippocampus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available